Janna Sand Dejmek

发表

Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results From a Proof-of-Concept, Phase Ib Study.

J. Blay, A. Italiano, S. Ferretti, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.